Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Intelligence | 2 | 2023 | 63 | 1.070 |
Why?
|
| Hospital Mortality | 4 | 2020 | 183 | 1.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 160 | 0.790 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 15 | 0.760 |
Why?
|
| Mitral Valve | 1 | 2020 | 22 | 0.760 |
Why?
|
| Computational Biology | 4 | 2023 | 275 | 0.720 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 48 | 0.690 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 65 | 0.500 |
Why?
|
| Biomedical Research | 3 | 2023 | 371 | 0.490 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2021 | 112 | 0.470 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2021 | 193 | 0.440 |
Why?
|
| Risk Assessment | 3 | 2019 | 727 | 0.320 |
Why?
|
| Treatment Outcome | 3 | 2019 | 1349 | 0.300 |
Why?
|
| Humans | 14 | 2023 | 34853 | 0.260 |
Why?
|
| United States | 5 | 2022 | 3894 | 0.260 |
Why?
|
| Bayes Theorem | 2 | 2021 | 91 | 0.230 |
Why?
|
| Reference Values | 1 | 2023 | 204 | 0.230 |
Why?
|
| SELEX Aptamer Technique | 1 | 2021 | 4 | 0.210 |
Why?
|
| Cisplatin | 1 | 2022 | 70 | 0.200 |
Why?
|
| Aptamers, Nucleotide | 1 | 2021 | 28 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2019 | 288 | 0.200 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 135 | 0.190 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 45 | 0.190 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 145 | 0.190 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 99 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 209 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2023 | 638 | 0.180 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2019 | 13 | 0.180 |
Why?
|
| Geography | 1 | 2019 | 86 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 23 | 0.170 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 2333 | 0.170 |
Why?
|
| Puerto Rico | 1 | 2023 | 1352 | 0.170 |
Why?
|
| ras Proteins | 1 | 2019 | 49 | 0.170 |
Why?
|
| Software | 2 | 2023 | 204 | 0.170 |
Why?
|
| Burns | 1 | 2018 | 8 | 0.160 |
Why?
|
| Platelet Aggregation | 1 | 2018 | 17 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 303 | 0.160 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 424 | 0.160 |
Why?
|
| Receptors, Immunologic | 1 | 2018 | 59 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 184 | 0.160 |
Why?
|
| Wound Healing | 1 | 2018 | 69 | 0.150 |
Why?
|
| Antifungal Agents | 1 | 2019 | 147 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 628 | 0.150 |
Why?
|
| Skin | 1 | 2018 | 173 | 0.150 |
Why?
|
| Algorithms | 2 | 2021 | 435 | 0.140 |
Why?
|
| Primary Health Care | 1 | 2019 | 283 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 282 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 781 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2019 | 486 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 446 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 756 | 0.120 |
Why?
|
| Risk Factors | 2 | 2019 | 3414 | 0.120 |
Why?
|
| Aged | 3 | 2019 | 6448 | 0.120 |
Why?
|
| Female | 6 | 2022 | 19873 | 0.110 |
Why?
|
| Placenta | 2 | 2022 | 91 | 0.100 |
Why?
|
| Male | 4 | 2019 | 18870 | 0.080 |
Why?
|
| Minority Groups | 2 | 2022 | 537 | 0.080 |
Why?
|
| Pregnancy | 2 | 2022 | 1503 | 0.070 |
Why?
|
| Nucleotides | 1 | 2023 | 33 | 0.060 |
Why?
|
| Writing | 1 | 2023 | 33 | 0.060 |
Why?
|
| Open Reading Frames | 1 | 2023 | 73 | 0.060 |
Why?
|
| Cystatin B | 1 | 2022 | 8 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 77 | 0.060 |
Why?
|
| Faculty | 1 | 2022 | 82 | 0.050 |
Why?
|
| Minority Health | 1 | 2022 | 81 | 0.050 |
Why?
|
| Language | 1 | 2023 | 143 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 271 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2022 | 36 | 0.050 |
Why?
|
| Decision Trees | 1 | 2021 | 18 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 133 | 0.050 |
Why?
|
| Natural Language Processing | 1 | 2021 | 10 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2021 | 23 | 0.050 |
Why?
|
| Gene Library | 1 | 2021 | 55 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2022 | 161 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 269 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 68 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 57 | 0.050 |
Why?
|
| Metabolomics | 1 | 2021 | 76 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 111 | 0.050 |
Why?
|
| Ligands | 1 | 2021 | 317 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 140 | 0.050 |
Why?
|
| Proteome | 1 | 2021 | 132 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 173 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 859 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 707 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 22 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2019 | 70 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 152 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 8 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 894 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 72 | 0.040 |
Why?
|
| Protein Binding | 1 | 2021 | 913 | 0.040 |
Why?
|
| Clone Cells | 1 | 2018 | 46 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 38 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 203 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 577 | 0.040 |
Why?
|
| Immunization | 1 | 2018 | 90 | 0.040 |
Why?
|
| Length of Stay | 1 | 2019 | 184 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 126 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2019 | 206 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2022 | 653 | 0.040 |
Why?
|
| Rabbits | 1 | 2018 | 278 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2018 | 74 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 600 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1149 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2018 | 834 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2128 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1124 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 751 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 308 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2561 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 639 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1425 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1681 | 0.030 |
Why?
|
| Child | 1 | 2019 | 2875 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 4012 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 5035 | 0.020 |
Why?
|
| Mice | 1 | 2018 | 5668 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 9642 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 11034 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 14307 | 0.010 |
Why?
|